[{"PropertyPlantAndEquipmentNet_0_Q2_USD":28710000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":260000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_0_Q2_USD":3.64,"InterestPaidNet_2_Q2_USD":577000.0,"BusinessCombinationContingentConsiderationLiability_0_Q2_USD":19337000.0,"AccruedLiabilitiesCurrent_0_Q2_USD":30203000.0,"RepaymentsOfLongTermCapitalLeaseObligations_2_Q2_USD":387000.0,"CommitmentsAndContingencies_0_Q2_USD":null,"FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_0_Q2_USD":1700000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q2_shares":222906000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_2_Q2_shares":211681000.0,"GeneralAndAdministrativeExpense_1_Q2_USD":16650000.0,"GeneralAndAdministrativeExpense_2_Q2_USD":33003000.0,"DepreciationAndAmortization_2_Q2_USD":3452000.0,"NetIncomeLossAttributableToNoncontrollingInterest_1_Q2_USD":-701000.0,"NetIncomeLossAttributableToNoncontrollingInterest_2_Q2_USD":-1427000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_0_Q2_USD":63679505.0,"IncreaseDecreaseInOtherOperatingCapitalNet_2_Q2_USD":1636000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":-2466000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_2_Q2_shares":7965208.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_0_Q2_USD":3.97,"OtherComprehensiveIncomeLossNetOfTax_1_Q2_USD":1262000.0,"OtherComprehensiveIncomeLossNetOfTax_2_Q2_USD":-2512000.0,"Assets_0_Q2_USD":192299000.0,"StockIssuedDuringPeriodValueIssuedForServices_1_Q2_USD":31000.0,"OtherLongTermDebtCurrent_0_Q2_USD":692000.0,"CommonStockSharesIssued_0_Q2_shares":225262889.0,"AccruedSalariesCurrent_0_Q2_USD":6682000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q2_USD":3072000.0,"ContractWithCustomerLiability_0_Q2_USD":42831000.0,"LongTermDebtCurrent_0_Q2_USD":838000.0,"AssetsCurrent_0_Q2_USD":92854000.0,"GoodwillForeignCurrencyTranslationGainLoss_2_Q2_USD":-746000.0,"InterestIncomeExpenseNonoperatingNet_1_Q2_USD":-16676000.0,"InterestIncomeExpenseNonoperatingNet_2_Q2_USD":-32566000.0,"StockIssuedDuringPeriodValueNewIssues_1_Q2_USD":9147000.0,"ShareBasedCompensation_2_Q2_USD":9589000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_2_Q2_USD":3.05,"ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_0_Q2_shares":1214816.0,"PreferredStockDividendsIncomeStatementImpact_1_Q2_USD":53000.0,"PreferredStockDividendsIncomeStatementImpact_2_Q2_USD":105000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_0_Q2_USD":2.69,"AccountsReceivableNetCurrent_0_Q2_USD":1436000.0,"BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_0_Q2_USD":19300000.0,"PrepaidExpenseCurrent_0_Q2_USD":13628000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_0_Q2_shares":14730962.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_2_Q2_shares":1813651.0,"MinorityInterest_0_Q2_USD":-8634000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_0_Q2_USD":2200000.0,"FiniteLivedIntangibleAssetsAccumulatedAmortization_0_Q2_USD":12813000.0,"IncreaseDecreaseInPrepaidExpense_2_Q2_USD":2895000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0_Q2_USD":3.64,"ResearchAndDevelopmentExpense_1_Q2_USD":45508000.0,"ResearchAndDevelopmentExpense_2_Q2_USD":82184000.0,"CommonStockValue_0_Q2_USD":2253000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_2_Q2_USD":2.87,"StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_1_Q2_USD":4321000.0,"CapitalizedContractCostNet_0_Q2_USD":0.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":34808000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":73543000.0,"OtherAssetsNoncurrent_0_Q2_USD":4153000.0,"IncreaseDecreaseInAccountsPayable_2_Q2_USD":1896000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_1_Q2_USD":-83343000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_2_Q2_USD":-137072000.0,"NonfinancialLiabilitiesFairValueDisclosure_0_Q2_USD":4127000.0,"OtherAssetsCurrent_0_Q2_USD":4247000.0,"IndefinitelivedIntangibleAssetsAcquired_2_Q2_USD":2038000.0,"BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_2_Q2_USD":13256000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":74754000.0,"FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_1_Q2_USD":-14300000.0,"FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_2_Q2_USD":-13256000.0,"IntangibleAssetsGrossExcludingGoodwill_0_Q2_USD":22407000.0,"CashAndCashEquivalentsPeriodIncreaseDecrease_2_Q2_USD":26300000.0,"ProceedsFromIssuanceOrSaleOfEquity_2_Q2_USD":70005000.0,"IncreaseDecreaseInContractWithCustomerLiability_2_Q2_USD":-2488000.0,"OperatingLeaseRightOfUseAsset_0_Q2_USD":32282000.0,"TreasuryStockRetiredCostMethodAmount_1_Q2_USD":1492000.0,"LiabilitiesCurrent_0_Q2_USD":168754000.0,"CostOfRevenue_1_Q2_USD":667000.0,"CostOfRevenue_2_Q2_USD":1772000.0,"RepaymentsOfDebt_2_Q2_USD":462000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-98301000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":5431000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_2_Q2_USD":5.71,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_2_Q2_shares":530919.0,"Goodwill_0_Q2_USD":24706000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q2_USD":49528000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_0_Q2_USD":600000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_0_Q2_shares":33789243.0,"ContractWithCustomerLiabilityRevenueRecognized_2_Q2_USD":2453000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_0_Q2_USD":600000.0,"AssetImpairmentCharges_2_Q2_USD":0.0,"AccountsPayableCurrent_0_Q2_USD":19164000.0,"IncreaseDecreaseInAccountsReceivable_2_Q2_USD":263000.0,"NonoperatingIncomeExpense_2_Q2_USD":1938000.0,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_2_Q2_USD":-280000.0,"SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_0_Q2_USD":23402449.0,"BusinessCombinationContingentConsiderationLiabilityNoncurrent_0_Q2_USD":4127000.0,"CapitalExpendituresIncurredButNotYetPaid_2_Q2_USD":1159000.0,"StockIssuedDuringPeriodSharesStockOptionsExercised_2_Q2_shares":1703924.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_2_Q2_shares":1485651.0,"StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0_Q2_USD":-255752000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_0_Q2_USD":76212000.0,"AdditionalPaidInCapital_0_Q2_USD":1353243000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_0_Q2_USD":63679505.0,"OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_1_Q2_USD":1262000.0,"OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_2_Q2_USD":-2512000.0,"IntangibleAssetsNetExcludingGoodwill_0_Q2_USD":9594000.0,"CommonStockSharesHeldInEmployeeTrust_0_Q2_USD":1275000.0,"OtherAccruedLiabilitiesCurrent_0_Q2_USD":5355000.0,"LongTermDebtNoncurrent_0_Q2_USD":18947000.0,"NonoperatingIncomeExpense_1_Q2_USD":-920000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_2_Q2_USD":3.15,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":-26293000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q2_shares":33789243.0,"PreferredStockSharesAuthorized_0_Q2_shares":5000000.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":192299000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_2_Q2_USD":3.14,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_2_Q2_USD":3.38,"ContractWithCustomerLiabilityCurrent_0_Q2_USD":28153000.0,"IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities_2_Q2_USD":3495000.0,"OperatingIncomeLoss_1_Q2_USD":-66395000.0,"OperatingIncomeLoss_2_Q2_USD":-107766000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q2_USD":10730000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_2_Q2_USD":22449000.0,"CommonStockSharesAuthorized_0_Q2_shares":400000000.0,"LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities_0_Q2_USD":19785000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_2_Q2_USD":1.99,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.01,"PreferredStockParOrStatedValuePerShare_0_Q2_USD":0.01,"AllocatedShareBasedCompensationExpense_2_Q2_USD":9363000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-1602874000.0,"AllocatedShareBasedCompensationExpense_1_Q2_USD":5431000.0,"StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants_1_Q2_USD":70000.0,"RestrictedCashAndCashEquivalents_0_Q2_USD":2669000.0,"DebtInstrumentCarryingAmount_0_Q2_USD":20000000.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":2466000.0,"ContractWithCustomerLiabilityNoncurrent_0_Q2_USD":14828000.0,"StockholdersEquity_0_Q2_USD":-247118000.0,"OtherLiabilitiesCurrent_0_Q2_USD":25456000.0,"OtherLiabilitiesNoncurrent_0_Q2_USD":1750000.0,"ProfitLoss_1_Q2_USD":-83991000.0,"ProfitLoss_2_Q2_USD":-138394000.0,"EarningsPerShareBasicAndDiluted_1_Q2_USD":-0.37,"EarningsPerShareBasicAndDiluted_2_Q2_USD":-0.65,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_2_Q2_USD":854000.0,"RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_2_Q2_USD":156000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_0_Q2_USD":1100000.0,"OperatingLeaseLiabilityCurrent_0_Q2_USD":2258000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_2_Q2_shares":908023.0,"AccruedProfessionalFeesCurrent_0_Q2_USD":6180000.0,"Ticker":"AGEN","CIK":"1098972","name":"AGENUS INC","OfficialName":"Agenus Inc. Common Stock","form":"10-Q","period":"20210630","fy":"2021.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"591453878.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20210809"}]